Evidence map›Paper›PMID 26622630›Full record

ArticleOncology letters2015

Advanced renal cell carcinoma associated with von Hippel-Lindau disease: A case report and review of the literature.

Lei Zhang, Bin Xu, Yiduo Wang, Chunhui Liu, Kai Lu, Yeqing Huang, Ning Liu, Xiaowen Zhang, Shuqiu Chen, Ming Chen

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Lei ZhangDepartment of Urology, Zhongda Hospital, Southeast University, Nanjing, Jiangsu 210009, P.R. China ; Surgical Research Center, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, P.R. China ; Institute of Urology, Southeast University, Nanjing, Jiangsu 210009, P.R. China.
Bin XuDepartment of Urology, Zhongda Hospital, Southeast University, Nanjing, Jiangsu 210009, P.R. China ; Surgical Research Center, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, P.R. China ; Institute of Urology, Southeast University, Nanjing, Jiangsu 210009, P.R. China.
Yiduo WangDepartment of Urology, Zhongda Hospital, Southeast University, Nanjing, Jiangsu 210009, P.R. China.
Chunhui LiuSurgical Research Center, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, P.R. China ; Institute of Urology, Southeast University, Nanjing, Jiangsu 210009, P.R. China.
Kai LuDepartment of Urology, Zhongda Hospital, Southeast University, Nanjing, Jiangsu 210009, P.R. China.
Yeqing HuangSurgical Research Center, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, P.R. China ; Institute of Urology, Southeast University, Nanjing, Jiangsu 210009, P.R. China.
Ning LiuDepartment of Urology, Zhongda Hospital, Southeast University, Nanjing, Jiangsu 210009, P.R. China.
Xiaowen ZhangDepartment of Urology, Zhongda Hospital, Southeast University, Nanjing, Jiangsu 210009, P.R. China ; Surgical Research Center, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, P.R. China ; Institute of Urology, Southeast University, Nanjing, Jiangsu 210009, P.R. China.
Shuqiu ChenDepartment of Urology, Zhongda Hospital, Southeast University, Nanjing, Jiangsu 210009, P.R. China.
Ming ChenDepartment of Urology, Zhongda Hospital, Southeast University, Nanjing, Jiangsu 210009, P.R. China ; Surgical Research Center, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, P.R. China ; Institute of Urology, Southeast University, Nanjing, Jiangsu 210009, P.R. China.
Southeast University · CNZhongda Hospital Southeast University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The autosomal dominant hereditary disorder von Hippel-Lindau (VHL) disease is caused by a germline mutation in the VHL gene. The symptoms of VHL include hemangioblastoma of the central nervous system, retinal angiomas, visceral tumors and multiple visceral cysts. However, advanced renal cell carcinoma (RCC) occurs in few VHL patients at initial diagnosis; in addition, sporadic VHL disease with

Indexed as

genetic screeningkidney cancersporadicvon Hippel-Lindau disease

Identifiers

PMID26622630
PMCPMC4509118
OpenAlexW1533550588

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.